Neuroscience
Psychosis
100%
Antipsychotic
71%
Dementia Praecox
40%
Affective Psychosis
31%
Olanzapine
28%
Risperidone
27%
Haloperidol
27%
Brain
23%
Polymorphism
19%
Gene
18%
Ziprasidone
17%
Aripiprazole
17%
Quetiapine
14%
Genotype
11%
Electroencephalography
11%
Interleukin 1 Receptor Antagonist
11%
Magnetic Resonance Imaging
11%
Glutamic Acid
11%
White Matter
11%
Negative Syndrome
9%
Diffusion Tensor Imaging
9%
Lipid
8%
Cognitive Disorders
8%
Gray Matter
8%
Insulin
8%
Schizophrenia Spectrum Disorder
7%
Glucose
6%
Magnetic Resonance Imaging
6%
Fractional Anisotropy
6%
Cognitive Function
6%
Anterior Cingulate Cortex
6%
Single-Nucleotide Polymorphism
5%
Methyltransferase
5%
Dysbindin
5%
Serotonin Transporter
5%
Psychiatry
5%
Energy Balance
5%
Open-Label Trial
5%
Peptide
5%
Body Mass Index
5%
Cholesterol
5%
Leptin
5%
Medicine and Dentistry
Psychosis
53%
Patient
32%
Typical Antipsychotic
29%
Therapeutic Procedure
23%
Brain
19%
Magnetic Resonance Imaging
17%
Disease
14%
Spontaneous Remission
13%
Affective Psychosis
12%
White Matter
11%
Haloperidol
11%
Olanzapine
11%
Risperidone
11%
Electroencephalogram
11%
Glutamic Acid
11%
Morphometrics
11%
Follow up
10%
Thalamus
8%
Symptom
8%
Analysis
7%
Anterior Cingulate
7%
Proton Nuclear Magnetic Resonance
7%
Cingulate Cortex
7%
Cognitive Defect
6%
Diffusion Tensor Imaging
6%
Enalapril Maleate
6%
Severe Mental Illness
5%
Discharge
5%
Alcohol Consumption
5%
Pregnancy
5%
Smoking
5%
Psychiatry
5%
Medication
5%
Genotype
5%
Interleukin 1 Receptor Blocking Agent
5%
Drug Therapy
5%
Psychology
Treatment
41%
Schizophrenia
28%
Groups
22%
Weight Gain
18%
Haloperidol
18%
Smoking
17%
Glutamate
11%
Polymorphism
11%
Cognitive Functioning
9%
Processing Speed
9%
Early Intervention
8%
Mental Illness
7%
Clinical Trial
6%
Behavior
6%
Anterior Cingulate Cortex
6%
Attitude and Beliefs
5%
Pregnancy
5%
Behavioral Intervention
5%
Questionnaires
5%
Hazard Ratio
5%
Critical Period
5%
Magnetic Resonance Imaging
5%
Cognition
5%
Alcohol
5%
Catechol-O-Methyltransferase
5%
